Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Plasmodium vivax pre-erythrocytic stage encompasses the parasite's development within hepatocytes, following transmission by a mosquito and preceding the blood-stage infection. This crucial stage involves sporozoite invasion, schizont formation, and the unique generation of dormant hypnozoites, which are responsible for relapses. Targeting this stage is vital for malaria prevention and eradication, focusing on sporozoite blocking or hypnozoite elimination.
Primaquine and tafenoquine target and eliminate hypnozoites, preventing relapse. Pre-erythrocytic vaccines aim to prevent sporozoite invasion or eliminate infected hepatocytes.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Plasmodium vivax pre-erythrocytic stage.